The one stop source for breaking news, expert analysis, and podcasts on fast-moving AIM and LSE listed shares
Results: NCYT
Search articles by EPIC code
views
Novacyt – details of the legal claim that could bankrupt it & which begs massive questions of £9m Graham Mullis
The Times has got hold of papers relating to the £134.6 million breach of contract claim made by the Government against Novacyt (NCYT), we reported here back in April, and this really looks as if it could bankrupt the company, currently sitting on c£90 million of cash. It also begs even more questions for ex CEO Graham Mullis who, if the Government is correct should be in jail for a £9 million bezzle not running Aquis listed Love Hemp (LIFE).
- By Tom Winnifrith, the Sheriff of AIM
- 2022-10-10 10:15:33
NEWSFLOW
Novacyt (#NCYT) – H1 £5m continuing operations loss on revenue down to £16.5m, cash down to £99.6m
- 2022-09-29 07:58:29
NEWSFLOW
Novacyt (#NCYT) – UK approval for covid “Direct Real-Time PCR test”, no financials (natch)
- 2022-07-15 07:53:55
NEWSFLOW
Novacyt (#NCYT) – H1 revenue down to £16.5m with faster than anticipated covid decline, notes cash burn
- 2022-07-07 07:53:00
NEWSFLOW
Novacyt (#NCYT) – attempts to join another bandwagon with PCR monkeypox assay
- 2022-06-28 07:52:33
views
Novacyt – receives £134.6 million claim from Government – this is all to do with the bonus of ex CEO Graham Mullis and stinks.
As folks guzzled on the covid testing hype, one man grew very rich. Graham Mullis was CEO of Novacyt (NCYT), a nothing biotech perennial dog, which just happened to have a test. Mullis was to be awarded a cash bonus, the size of which was dependent on the share price as of October 17 2020.
- By Tom Winnifrith, the Sheriff of AIM
- 2022-04-26 14:35:58
NEWSFLOW
Novacyt (#NCYT) – first ‘direct-to-PCR’ covid test approved in UK, but what’s the demand?
- 2022-02-17 07:58:59
